Valvular & structural heart disease

Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR

Circ Cardiovasc IntervPublished Prospective registry cohort study

Main findingResult — go to the resultSubdistribution hazard ratio 0.37 95% CI 0.15–0.95

Authors' conclusion

BPD was associated with a lower incidence of stage 2 and 3 hemodynamic valve deterioration and bioprosthetic valve failure, along with improved bioprosthetic valve hemodynamic parameters over time.

Study context

Population
Consecutive patients undergoing TAVR (May 2007–March 2024) alive at 1 year and without valve-in-valve procedurematched cohort
Participants
1,911 patients
Exposure
Balloon postdilation (BPD) vs no BPD during TAVR
  • BPDn = 215
  • No-BPDn = 761reference
Outcome
Stage 2 or 3 hemodynamic valve deterioration (VARC-3)
Methodological detailssingle-centre, propensity-score matched
  • Single-centre
  • Propensity-score matched

Main finding

As reported in the abstract

Subdistribution hazard ratio

0.37

95% CI 0.15–0.95

P = 0.039

By group

BPDvs No-BPD
subdistribution HR 0.37 (95% CI 0.15–0.95); P = 0.039

Observational data: associations, not effects.

Further findings

OutcomeNo-BPDSubdistribution HR (95% CI)P value
Bioprosthetic valve failure5.1%0.39 (0.15–0.98)P = 0.046

Echocardiographic hemodynamic parameters · up to 10 years

Better hemodynamic parameters over time with BPD

HF hospitalization

Trend toward higher prevalence with BPD

Original publication

Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR. Circ Cardiovasc Interv. Published 28 October 2025. doi:10.1161/circinterventions.125.015577

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.